UK small-cap RNS · 25 Mar 2026
Every announcement of UK small & mid caps under £2bn. The ones that started or moved a situation are marked – a click opens it.
Key = all announcements except routine filings (voting rights, buybacks, holdings, director forms), plus the ones that are part of a situation. Not investment advice.
| Time | Company | Mcap ↕ | Type | Announcement | |
|---|---|---|---|---|---|
| 11:33 | City of London Investment Group CLIG | £217m | Insider conviction | Director/PDMR Shareholding | |
| 07:04 | Cobra Resources COBR | £35m | Project milestones | Result of Fundraise
Successful £4.5 million (net) fundraise enables Cobra to accelerate Manna Hill Copper Project drilling following a scalable copper discovery and to advance Boland Rare Earth Project through pre-feasibility |
|
| 07:00 | Pharos Energy PHAR | £121m | Disposal of a part (break-up) | 2025 Preliminary Results
("Pharos" or the "Company" or, together with its subsidiaries, the "Group") |
|
| 07:00 | W.A.G Payment Solutions EWG | £729m | Transformational contract / build-out | Final Results
W.A.G payment solutions plc ("Eurowag" or the "Group") |
|
| 07:00 | TT Electronics TTG | £331m | Turnaround plan with targets | Final Results
Results for the full year ended 31 December 2025 |
|
| 07:00 | Franchise Brands FRAN | £289m | Disposal of a part (break-up) | Final Results
Final results for the year ended 31 December 2025 |
|
| 07:00 | Luceco LUCE | £300m | Upgrade / downgrade cycle | 2025 Full Year Results
Continued momentum in Energy Transition drives 2025 profit growth and strong outlook 2026 earnings expected ahead of market consensus |
|
| 07:00 | Kore Potash KP2 | £186m | Balance-sheet stress / refinancing | Financial Results for Year Ended 31 December 2025
("Group" refers to Kore Potash Plc and its subsidiaries) |
|
| 07:00 | Kenmare Resources (CDI) KMR | £200m | Legal & regulatory | 2025 Preliminary Results
Kenmare Resources plc (LSE:KMR, ISE:KMR), one of the leading global producers of titanium minerals and zircon, which operates the Moma Titanium Minerals Mine (the "Mine" or "Moma") in northern Mozambique, today announces its preliminary results for the 12 … |
|
| 07:00 | Crism Therapeutics Corporation CRTX | £7.0m | Project milestones | Phase 2 Clinical Trial Progress Update
596/2014, as incorporated into UK law by the European Union (Withdrawal) Act 2018. |